Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CAH✓SelectedUSD · CAHMRNA vs CAH performance historyLatest closeAs of+5.38%09/11
Stock and ETF performance explorer

MRNA vs CAH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-65.7%
CAH return
+393.5%
Excess return
-459.2%
Maximum drawdown
-95.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCAHExcessAlpha
1D+5.4%-0.6%+6.0%+5.5%
7D-1.1%-5.1%+4.0%-0.1%
30D+126.1%+0.2%+125.9%+126.5%
3M+190.0%+6.3%+183.7%+187.2%
6M+157.2%+9.4%+147.8%+153.4%
YTD+388.2%+15.0%+373.2%+374.8%
1Y+467.0%+55.4%+411.6%+421.8%
3Y+36.1%+173.8%-137.7%+14.5%
All-65.7%+393.5%-459.2%-70.9%

Cumulative growth

Daily Returns

Daily percentage return beside CAH.

Daily Out/Under-Performance

Portfolio return minus CAH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CAH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CAH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling